Platelet Pharmacology and Therapy Volume 5 /
This five-volume series provides clinicians with a detailed, up-to-date, well-referenced overview of the latest developments in this rapidly expanding feld. It serves as an authoritative guide to the diagnosis and treatment of platelet disorders.The primary audience for the series is clinicians, res...
محفوظ في:
| مؤلف مشترك: | |
|---|---|
| مؤلفون آخرون: | , , , |
| التنسيق: | الكتروني كتاب الكتروني |
| اللغة: | الإنجليزية |
| منشور في: |
Cham :
Springer Nature Switzerland : Imprint: Springer,
2025.
|
| الطبعة: | 1st ed. 2025. |
| سلاسل: | Platelets in Thrombotic and Non-Thrombotic Disorders,
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1007/978-3-031-96360-5 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-3-031-96360-5 | ||
| 003 | DE-He213 | ||
| 005 | 20260810165444.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 251015s2025 sz | o |||| 0|eng d | ||
| 020 | |a 9783031963605 |9 978-3-031-96360-5 | ||
| 024 | 7 | |a 10.1007/978-3-031-96360-5 |2 doi | |
| 050 | 4 | |a R1 | |
| 072 | 7 | |a MB |2 bicssc | |
| 072 | 7 | |a MED000000 |2 bisacsh | |
| 072 | 7 | |a MB |2 thema | |
| 082 | 0 | 4 | |a 610 |2 23 |
| 245 | 1 | 0 | |a Platelet Pharmacology and Therapy |h [electronic resource] : |b Volume 5 / |c edited by Paolo Gresele, José A. López, Dominick J. Angiolillo, Clive P. Page. |
| 250 | |a 1st ed. 2025. | ||
| 264 | 1 | |a Cham : |b Springer Nature Switzerland : |b Imprint: Springer, |c 2025. | |
| 300 | |a 1 online resource (XVIII, 300 p. 44 illus.). |b 38 illus. in color. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b PDF/UA-1 |2 onix | |
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of color is not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background color |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Platelets in Thrombotic and Non-Thrombotic Disorders, |x 3005-1592 | |
| 505 | 0 | |a Chapter 106: Aspirin -- Chapter 107: P2Y12 inhibitors -- Chapter 108: GPIIb/IIIa antagonists -- Chapter 109: PAR antagonists -- Chapter 110: PDE-adenosine reuptake-inhibitor agents -- Chapter 111: Nitric oxide-releasing or enhancing agents -- Chapter 112: Platelet puringeric receptors as targets for novel anti-inflammatory drugs -- Chapter 113: Novel approaches to antiplatelet therapy -- Chapter 114: Antiplatelet therapy in coronary artery disease -- Chapter 115: Antiplatelet therapy for TIA/stroke -- Chapter 116: Antiplatelet therapy for PAD -- Chapter 117: Laboratory monitoring-guided antiplatelet therapy -- Chapter 118: Antiplatelet therapy for venous thromboembolism -- Chapter 119: Platelets in regenerative medicine -- Chapter 120: Platelet transfusions -- Chapter 121: TPO agonists and agents under development to increase platelet count -- Chapter 122: In vitro generated engineered or enhanced platelets -- Chapter 123: Platelets for gene therapy -- Chapter 124: Platelets as carriers for antitumor therapy. | |
| 520 | |a This five-volume series provides clinicians with a detailed, up-to-date, well-referenced overview of the latest developments in this rapidly expanding feld. It serves as an authoritative guide to the diagnosis and treatment of platelet disorders.The primary audience for the series is clinicians, residents and fellows in internal medicine, cardiology and haematology, as well as clinicians (e.g. neurologists, nephrologists, rheumatologists) and basic scientists who may be concerned with disorders and cellular mechanisms involving platelets. | ||
| 532 | 8 | |a Accessibility summary: This PDF has been created in accordance with the PDF/UA-1 standard to enhance accessibility, including screen reader support, described non-text content (images, graphs), bookmarks for easy navigation, keyboard-friendly links and forms and searchable, selectable text. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. Please note that a more accessible version of this eBook is available as ePub. | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 588 | |a Print version record. | ||
| 650 | 0 | |a Medical sciences. | |
| 650 | 0 | |a Hematology. | |
| 650 | 0 | |a Pharmacology. | |
| 650 | 0 | |a Human physiology. | |
| 650 | 0 | |a Cardiology. | |
| 650 | 1 | 4 | |a Health Sciences. |
| 650 | 2 | 4 | |a Hematology. |
| 650 | 2 | 4 | |a Pharmacology. |
| 650 | 2 | 4 | |a Human Physiology. |
| 650 | 2 | 4 | |a Cardiology. |
| 700 | 1 | |a Gresele, Paolo. |e editor. |0 (orcid)0000-0001-5365-8445 |1 https://orcid.org/0000-0001-5365-8445 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a López, José A. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Angiolillo, Dominick J. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Page, Clive P. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783031963599 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031963612 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031963629 |
| 830 | 0 | |a Platelets in Thrombotic and Non-Thrombotic Disorders, |x 3005-1592 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-031-96360-5 |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 912 | |a ZDB-2-226 | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||
| 950 | |a Focus Bundle Primary Care, Public and Allied Health (SpringerNature-85396) | ||